从“火与元气不两立”探讨子宫颈癌的病机及防治

中华养生保健 ›› 2024, Vol. 42 ›› Issue (13): 72-76.

从“火与元气不两立”探讨子宫颈癌的病机及防治

邱佳慧^1,2,3, 纪立金⁴, 许金榜^1,*

1.福建省妇幼保健院福建医科大学附属医院中医科,福建福州,350001;
2.福建省妇产医院中医科,福建福州,350012;
3.福建省妇幼保健院福建医科大学妇儿临床医学院中医科,福建福州,350001;
4.福建中医药大学中医学院,福建福州,350122

出版日期:2024-07-01 发布日期:2024-06-25
通讯作者: ^*许金榜,E-mail：75157335@qq.com。
作者简介:邱佳慧（1990—）,女,汉族,籍贯：浙江省丽水市,博士研究生,主治医师,研究方向：中医妇科肿瘤、中医脾胃、中医藏象理论。
基金资助:
福建省自然科学基金项目（2021J05078）; 福建省科技创新联合资金项目（2020Y9153）; 福建医科大学启航基金项目资助（2020QH1205）; 福建省妇幼保健院科技创新启动基金（妇幼YCXY20-11）

To Discuss the Pathogenesis Prevention and Treatment of Cervical Cancer from the "Fire and Original Qi in Compatibility"

QIU Jia-hui^1,2,3, JI Li-jin⁴, XU Jin-bang^1,*

1. Departments of TCM, Fujian Maternity and Child Health Hospital Affiliated Hospital of Fujian Medical University, Fuzhou Fujian 350001, China;
2. Departments of TCM, Fujian Obstetrics and Gynecology Hospital, Fuzhou Fujian 350012, China;
3. Departments of TCM, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou Fujian 350001, China;
4. College of TCM, Fujian University of TCM, Fuzhou Fujian 350122, China

Online:2024-07-01 Published:2024-06-25

摘要/Abstract

摘要： 子宫颈癌是常见的妇科恶性肿瘤,文章以其临床症状切入,结合“火与元气不两立”之理,提出子宫颈癌各阶段频频呈现正邪相互博弈一负一胜的病理表现,并指出正邪博弈的关键在于脾枢调衡,阐明脾虚枢机不利是子宫颈癌的核心病机,健脾调枢是治疗方法。选用补脾胃泻阴火升阳汤为主方治疗,并论述各阶段病机特点及防治要点,指导主方临证加减,具体如下：发病前,湿盛、阴不足并见,加予祛湿养阴;发病早期,正气不足是决定发病的关键因素,加予补气,辅以抗邪;发病中期,湿盛瘀毒下注营造利于癌灶生长的局部环境,加予祛湿化瘀攻毒,辅以补养气血;发病晚期,湿盛瘀毒下注、日久气血虚衰,加予补养气血,酌以祛湿化瘀攻毒。康复期,病灶去,气血耗伤,机体仍属脾虚枢机不利,以防复为主,补养气血、健脾调枢。

关键词: 子宫颈癌, 火与元气不两立, 脾虚枢机不利, 补脾胃泻阴火升阳汤

Abstract: Cervical cancer is a common gynecological malignancy. Based on the clinical symptoms, combined with the mechanism of "fire and original qi incompatibility", the paper proposes that cervical cancer frequently presents pathological manifestations of healthy qi and pathogenic factor game which is one loses and one wins in each stage. It points out that the key of the game between healthy qi and pathogenic factor lies in spleen regulating qi activity to achieve balance, expounds that spleen deficiency is unfavorable to regulate qi activity is the core pathogenesis of cervical cancer and strengthening the spleen to regulate qi activity is the treatment method. Choosing the main prescription of Bupiwei Xieyinhuo Shengyang Decoction for treatment, At the same time, the pathogenesis characteristics and the prevention and treatment points of each stage are elaborated on, Guiding the addition and subtraction of medication in the main prescription. The methods are as follows: Before onset, dampness excess and yin deficiency. To remove dampness and nourish yin. In the early stage of the disease, lack of healthy qi is the key factor that determines the disease. To benefit qi with resisting pathogenic factor. In the middle stage of the disease, dampness excess, poison and stasis accumulating downward creates a local environment conducive to the growth of cancer focus. To remove dampness and transform stasis and attack poison, with benefiting qi and nourishing blood. The late stage of the disease, dampness excess, poison and stasis accumulate downward, and after a long time, qi and blood will be weak. To benefit qi and nourish blood, slightly remove dampness and transform stasis and attack poison. During the rehabilitation period, the lesion is removed, the qi and blood are consumed, and the body remains that spleen deficiency is unfavorable to regulate qi activity. Mainly to relapse prevention, benefit qi and nourish blood, strengthen the spleen to regulate qi activity.

Key words: cervical cancer, fire and original qi incompatibility, spleen deficiency is unfavorable to regulate qi activity, Bupiwei Xieyinhuo Shengyang Decoction

中图分类号:

R228

邱佳慧, 纪立金, 许金榜. 从“火与元气不两立”探讨子宫颈癌的病机及防治[J]. 中华养生保健, 2024, 42(13): 72-76.

QIU Jia-hui, JI Li-jin, XU Jin-bang. To Discuss the Pathogenesis Prevention and Treatment of Cervical Cancer from the "Fire and Original Qi in Compatibility"[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(13): 72-76.

参考文献

[1] 谢幸,马丁,孔北华.中医妇科恶性肿瘤临床实践指南[M].北京:人民卫生出版社,2020:36.
[2] TORRE L A, BRAY F, SIEGEL R L, et al.Global cancer statistics[J]. 2012.CA-CANCER J CLIN,2015,65(2):87-108.
[3] HANG D, JIA M, MA H, et al.Independent prognostic role of human papillomavirus genotype in cervical cancer[J]. BMC INFECT DIS,2017,17(1):391.
[4] 多晓玲,侯春丽,殷民.HPV卵黄抗体抑制HPV18 E6基因表达诱导宫颈癌细胞凋亡的研究[J].现代妇产科进展,2019,28(12):939-942.
[5] 郭悦,姚稚明,陈聪霞,等.18F-FDG PET/CT体积及肿瘤异质性参数对宫颈癌临床分期、病理类型及预后预测价值的研究[J].医学研究杂志,2019,48(11):136-143.
[6] 谢幸,孔北华,段涛.妇产科学[M].北京:人民卫生出版社,2018:254.
[7] 张玉珍. 中医妇科学[M].北京:中国中医药出版社,2002:311.
[8] 孙广仁,郑洪新.中医基础理论[M].北京:中国中医药出版社,2012:109.
[9] 李东垣. 脾胃论[M].北京:中国中医药出版社,2013:3.
[10] 王洪图,贺娟.黄帝内经素问白话解[M].北京:人民卫生出版社,2014:163.
[11] 邱佳慧,纪立金.论“火与元气不两立”[J].中华中医药杂志,2018,33(4):1297-1299.
[12] 纪立金. 中医脾脏论[M].北京:中医古籍出版社,2001,9:52.
[13] 何梦瑶. 医碥[M].北京:中医中医药出版社,2009,12:5.
[14] 乐杰. 妇产科学[M].北京:人民卫生出版社,2008,1:261,263.
[15] SCHIFFMAN M H, BAUER H M, HOOVER R N, et al.Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia[J]. JNCI-J NATL CANCER I,1993,85(12):958-964.
[16] 徐玲,赖凤娣,康川川,等.宫颈高危型人乳头瘤病毒持续性感染相关危险因素研究进展[J].赣南医学院学报,2019,39(4):385-389,395.
[17] SONG D, LI H, LI H, et al.Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer[J]. ONCOL LETT,2015,10(2):600-606.
[18] 刘建华,王萍.高危型HPV感染导致宫颈癌发生的风险评估[J].医学研究生学报,2017,30(12):1233-1237.
[19] 王静. 中药抗病毒制剂治疗年轻女性宫颈高危型HPV感染的临床观察[D].南京:南京中医药大学,2016.
[20] 刘君,薛晓鸥,马秀丽,等.高危型人乳头瘤病毒感染宫颈病变患者体质特点探析[J].中国中医药信息杂志,2020,27(1):14-18.
[21] 刘君,李娅,马秀丽,等.基于因子分析的宫颈高危型人乳头瘤病毒感染证素研究[J].上海中医药杂志,2022,56(8):27-29,36.
[22] 冯杰. CIN病理分级与HR-HPV拷贝量相关性及CIN合并HR-HPV感染中医证型分布特点研究[D].福州:福建中医药大学,2013.
[23] 孔咏霞. 人乳头瘤病毒阳性的宫颈上皮内瘤变中医证型分布与证候要素分析[D].西安:陕西中医药大学,2014.
[24] 吴桐桐,王志莲.HPV16相关宫颈癌中PI3K/Akt自噬通路与HIF-1α的关系[J].国际生殖健康/计划生育杂志,2022,41(2):172-176.
[25] 王佳森,张妍,付晓雪,等.宫颈癌免疫学发病机制研究进展[J].国际妇产科学杂志,2022,49(2):207-211.
[26] 李健芳,冯勤梅,孙晋瑞,等.阴道微生态与免疫微环境的变化对宫颈癌的影响[J].中国微生态学杂志,2022,34(4):493-497.
[27] DA SILVA D M, WOODHAM A W, SKEATE J G, et al. Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C[J]. CLIN IMMUNOL,2015,161(2):197-208.
[28] 李中梓. 医宗必读[M].天津:天津科学技术出版社,1999,4:256.
[29] 余景和. 外证医案汇编[M].北京:中国中医药出版社,2015.12:138.
[30] 王洪图,贺娟.黄帝内经灵枢白话解[M].北京:人民卫生出版社,2014:90.
[31] 袁嘉嘉. “炎—癌转化”的病因病机及防治策略研究[D].南京:南京中医药大学,2016.
[32] 方勇. 庄子[M].北京:中华书局,2015,6:285.
[33] 谭峰,李柳,唐东昕,等.基于癌毒病机理论探析扶正固本方药的应用思路及配伍规律[J].南京中医药大学学报,2022,38(2):93-97.
[34] 叶天士. 临证指南医案[M].北京:中国中医药出版社,2008,10:171.
[35] 魏华民,花宝金.中医治疗肿瘤转移新模式--转移前微环境干预[J].世界中医药,2016,11(10):2204-2208.
[36] 郎景和. 中华妇产科杂志临床指南荟萃[M].北京:人民卫生出版社,2015:364.
[37] PAGET S.The distribution of secondary growths in cancer of the breast[J]. CANCER METAST REV,1989,8(2):98-101.